Lawsuit Appeals Permit for Formosa Plastics to Build in Louisiana's 'Cancer Alley'
A coalition of local and national groups on Friday launched a legal challenge to a Louisiana state agency's decision to approve air permits for a $9.4 billion petrochemical complex that Taiwan-based Formosa Plastics Group plans to build in the region nationally known as "Cancer Alley."
Louisiana residents and environmental justice advocates have pressured local, state, and federal officials to reject permits for the proposed project in St. James Parish. Critics have raised concerns that the complex would adversely affect public health and the environment by emitting cancer-causing chemicals and producing an estimated 13.6 million tons of planet-heating emissions annually.
Earthjustice filed the new lawsuit (pdf) in the Louisiana 19th Judicial District Court on behalf of RISE St. James, the Louisiana Bucket Brigade, Center for Biological Diversity, Healthy Gulf, No Waste Louisiana, Earthworks, and the Sierra Club. The suit appeals the air permits issued by the Louisiana Department of Environmental Quality (LDEQ).
"Louisiana violated the Clean Air Act when it gave Formosa the greenlight to double toxic air pollution in St. James," Earthjustice attorney Corinne Van Dalen said in a statement. "It's time for LDEQ to put Louisianans first and reject more pollution that puts their health, safety, and environment at risk."
BREAKING: We’re challenging Louisiana’s decision to approve air permits for a massive proposed petrochemical comple… https://t.co/DzByCNCLGF— Earthjustice (@Earthjustice)1581708454.0
As the lawsuit explains:
LDEQ granted Formosa Plastics permits to construct 14 separate major facilities, including 10 chemical plants. The planned chemical complex would manufacture ethylene and propylene, primarily to produce plastics. The other four facilities would support these operations. Formosa Plastics would build this complex a mile from an elementary school in Welcome, and less than one mile from the community of Union in Convent. Its massive air pollution emissions would vastly add to the significant environmental and health burden that African American communities in and near St. James must suffer—including from two new recently permitted methanol petrochemical plants, and Nucor Steel's major expansion project.
Formosa Plastics' air emissions will also spread to communities across St. James Parish, contributing to the region's air pollution problems. The permits would allow Formosa Plastics to release fine particulates and nitrogen dioxide in quantities that exacerbate ongoing violations of EPA's mandatory national standards in St. James Parish. And they would allow Formosa Plastics to be one of the largest industrial sources in the state for some of the most dangerous carcinogenic air pollutants, such as benzene and formaldehyde, and one of the largest in the nation for others, such as ethylene oxide.
In an email to the Associated Press on Friday, LDEQ spokesperson Gregory Langley said that "we don't comment on ongoing litigation."
Anne Rolfes, director of the Louisiana Bucket Brigade, called the permit approval "a new low" for LDEQ, pointing out that the department received over 15,500 comments from residents opposing the complex.
"Formosa Plastics would be one of the largest plants in the world, but our state used the same old rubber stamp to approve the project," said Rolfes. "We will act to protect the people of Louisiana since the state has clearly failed to do so."
The proposed Formosa Plastics Plant would increase the cancer risk in the 7th District, according to @Earthjustice.… https://t.co/ikvsokUMG5— LA Bucket Brigade (@LA Bucket Brigade)1580509900.0
Sharon Lavigne, founder and president of the local organization RISE St. James, declared that "LDEQ doesn't care about people's lives."
"They should have consulted the citizens of St. James, not the public officials, before approving these permits. It just tells me that people in higher office can do what they want and poison an entire African American community," she said. "RISE is going to fight to save the lives of the people in our community. This approval is making our fight harder, but it's making us stronger, and we will fight until the end to stop Formosa."
Great profile of Sharon Lavigne, a leader in the fight to #StopFormosa and its massive plastic-making plant in Loui… https://t.co/Ot5eUS9esc— Ctr4BioDiv Ocean (@Ctr4BioDiv Ocean)1581702363.0
Representatives from national organizations signed on to the suit expressed support for the community members battling against the project but also put the fight into a broader context.
"This plant would poison the people of St. James Parish and worsen the climate crisis just so Formosa can churn out more throwaway plastic," said Lauren Packard, an attorney at the Center for Biological Diversity. "Using our oversupply of fracked gas to create products that add to the plastic pollution crisis is appalling. We stand with the local community in opposing this dangerous project."
As Common Dreams reported last month, Environmental Integrity Project found that greenhouse gas emissions from the U.S. oil, gas, and petrochemical industries could jump about 30% by 2025 compared with 2018 because of additional drilling and 157 new or expanded projects "fueled by the fracking boom." The Formosa complex would have the highest potential yearly emissions among all the future and petrochemical and plastics projects included in the analysis.
"The fight against Formosa's polluting and unjust petrochemical complex is part of a growing national movement to address the triple threat of climate chaos, plastics pollution, and environmental racism," Earthworks energy campaigner Ethan Buckner said Friday. "By issuing these permits to Formosa, LDEQ yet again acquiesced to the fossil fuel industry's reckless plans to rapidly expand in the face of our worsening climate crisis."
"As investors sour on oil and gas companies, plastics are Big Oil's lifeline. And LDEQ threw them the rope," Buckner added. "Yet the voices of Cancer Alley's leaders are stronger than ever, and we will defend their right to clean water, air, and a stable climate."
Reposted with permission from Common Dreams.
- Environmental Justice Activists Arrested Amid Growing Concerns ... ›
- Formosa Plant May Still Be Releasing Plastic Pollution in Texas ... ›
- Plastics Plant Will Bulldoze Over Black History in 'Cancer Alley ... ›
EcoWatch Daily Newsletter
Anyone entering a U.S. Starbucks from July 15 will have to wear a face mask, the company announced Thursday.
- 3 Ways to Go Plastic-Free This July While Staying Safe From ... ›
- Starbucks Is Testing Fully Compostable Cups in Five Cities ... ›
- Reusable Cups, Bags and Containers Can Be Safe During COVID ... ›
- Starbucks Becomes Largest Food and Beverage Retailer to ... ›
On Monday and Tuesday of the week that President Donald Trump held his first rally since March in Tulsa, Oklahoma, the county reported 76 and 96 new coronavirus cases respectively, according to POLITICO. This week, the county broke its new case record Monday with 261 cases and reported a further 206 cases on Tuesday. Now, Tulsa's top public health official thinks the rally and counterprotest "likely contributed" to the surge.
- No Social Distancing or Mask Requirement at Trump's Mt ... ›
- Trump Plans to End Federal Funding for COVID-19 Testing Sites ... ›
- Attendees at Trump's First Rally Since March Can't Sue if They Get ... ›
Rainforests are an important defense against climate change because they absorb carbon. But many are being destroyed on a massive scale.
- Brazil's Amazon Rainforest Is the Wild West for Illegal Gold Miners ... ›
- Trump Moves to Open 16.7 Million Acre Alaskan Rainforest to ... ›
- Amazon Rainforest Reaches Point of No Return - EcoWatch ›
As we look for advanced technology to replace our dependence on fossil fuels and to rid the oceans of plastic, one solution to the climate crisis might simply be found in rocks. New research found that dispersing rock dust over farmland could suck billions of tons of carbon dioxide from the air every year, according to the first detailed large scale analysis of the technique, as The Guardian reported.
- California Startup Opus 12 Recycles Carbon Dioxide - EcoWatch ›
- UK Biomass Plant Starts Groundbreaking Carbon Capture Project ... ›
- 8 Ways to Sequester Carbon to Avoid Climate Catastrophe - EcoWatch ›
By Tim Radford
German scientists now know why so many fish are so vulnerable to ever-warming oceans. Global heating imposes a harsh cost at the most critical time of all: the moment of spawning.
Nearing the Brink<p>Since <a href="https://climatenewsnetwork.net/abundant-fish-need-cool-seas-and-protection/" target="_blank">fish in the temperate zones already experience a wide variation</a> in seasonal water temperatures, it hasn't been obvious why species such as <a href="https://climatenewsnetwork.net/sardines-swim-into-northern-waters-to-keep-cool/" target="_blank">cod have shifted nearer the Arctic, and sardines have migrated to the North Sea</a>.</p><p>But <a href="https://climatenewsnetwork.net/ocean-warming-spurs-marine-life-to-rapid-migration/" target="_blank">marine creatures are on the move</a>, and although there are other factors at work, including overfishing and <a href="https://climatenewsnetwork.net/fish-cant-smell-well-in-more-acidic-seas/" target="_blank">the increasingly alarming changes in ocean chemistry</a>, thanks to ever-higher levels of dissolved carbon dioxide, temperature change is part of the problem.</p><p>The latest answer, Dr Dahlke and his colleagues report in the journal <a href="https://science.sciencemag.org/cgi/doi/10.1126/science.aaz3658" target="_blank">Science</a>, is that many fish may already be living near the limits of their thermal tolerance.</p><p>The temperature safety margins during the moments of spawning and embryo might be very precise, and over hundreds of thousands of years of evolution, marine and freshwater species have worked out just what is best for the next generation. Rapid global warming upsets this equilibrium.</p>
By Sherry H-Y. Chou, Aarti Sarwal and Neha S. Dangayach
The patient in the case report (let's call him Tom) was 54 and in good health. For two days in May, he felt unwell and was too weak to get out of bed. When his family finally brought him to the hospital, doctors found that he had a fever and signs of a severe infection, or sepsis. He tested positive for SARS-CoV-2, the virus that causes COVID-19 infection. In addition to symptoms of COVID-19, he was also too weak to move his legs.
When a neurologist examined him, Tom was diagnosed with Guillain-Barre Syndrome, an autoimmune disease that causes abnormal sensation and weakness due to delays in sending signals through the nerves. Usually reversible, in severe cases it can cause prolonged paralysis involving breathing muscles, require ventilator support and sometimes leave permanent neurological deficits. Early recognition by expert neurologists is key to proper treatment.
We are neurologists specializing in intensive care and leading studies related to neurological complications from COVID-19. Given the occurrence of Guillain-Barre Syndrome in prior pandemics with other corona viruses like SARS and MERS, we are investigating a possible link between Guillain-Barre Syndrome and COVID-19 and tracking published reports to see if there is any link between Guillain-Barre Syndrome and COVID-19.
Some patients may not seek timely medical care for neurological symptoms like prolonged headache, vision loss and new muscle weakness due to fear of getting exposed to virus in the emergency setting. People need to know that medical facilities have taken full precautions to protect patients. Seeking timely medical evaluation for neurological symptoms can help treat many of these diseases.
What Is Guillain-Barre Syndrome?
Guillain-Barre syndrome occurs when the body's own immune system attacks and injures the nerves outside of the spinal cord or brain – the peripheral nervous system. Most commonly, the injury involves the protective sheath, or myelin, that wraps nerves and is essential to nerve function.
Without the myelin sheath, signals that go through a nerve are slowed or lost, which causes the nerve to malfunction.
To diagnose Guillain-Barre Syndrome, neurologists perform a detailed neurological exam. Due to the nerve injury, patients often may have loss of reflexes on examination. Doctors often need to perform a lumbar puncture, otherwise known as spinal tap, to sample spinal fluid and look for signs of inflammation and abnormal antibodies.
Studies have shown that giving patients an infusion of antibodies derived from donated blood or plasma exchange – a process that cleans patients' blood of harmful antibodies - can speed up recovery. A very small subset of patients may need these therapies long-term.
The majority of Guillain-Barre Syndrome patients improve within a few weeks and eventually can make a full recovery. However, some patients with Guillain-Barre Syndrome have lingering symptoms including weakness and abnormal sensations in arms and/or legs; rarely patients may be bedridden or disabled long-term.
Guillain-Barre Syndrome and Pandemics
As the COVID-19 pandemic sweeps across the globe, many neurologic specialists have been on the lookout for potentially serious nervous system complications such as Guillain-Barre Syndrome.
Though Guillain-Barre Syndrome is rare, it is well known to emerge following bacterial infections, such as Campylobacter jejuni, a common cause of food poisoning, and a multitude of viral infections including the flu virus, Zika virus and other coronaviruses.
Studies showed an increase in Guillain-Barre Syndrome cases following the 2009 H1N1 flu pandemic, suggesting a possible connection. The presumed cause for this link is that the body's own immune response to fight the infection turns on itself and attacks the peripheral nerves. This is called an "autoimmune" condition. When a pandemic affects as many people as our current COVID-19 crisis, even a rare complication can become a significant public health problem. That is especially true for one that causes neurological dysfunction where the recovery takes a long time and may be incomplete.
Though there is clear clinical suspicion that COVID-19 can lead to Guillain-Barre Syndrome, many important questions remain. What are the chances that someone gets Guillain-Barre Syndrome during or following a COVID-19 infection? Does Guillain-Barre Syndrome happen more often in those who have been infected with COVID-19 compared to other types of infections, such as the flu?
The only way to get answers is through a prospective study where doctors perform systematic surveillance and collect data on a large group of patients. There are ongoing large research consortia hard at work to figure out answers to these questions.
Understanding the Association Between COVID-19 and Guillain-Barre Syndrome
While large research studies are underway, overall it appears that Guillain-Barre Syndrome is a rare but serious phenomenon possibly linked to COVID-19. Given that more than 10.7 million cases have been reported for COVID-19, there have been 10 reported cases of COVID-19 patients with Guillain-Barre Syndrome so far – only two reported cases in the U.S., five in Italy, two cases in Iran and one from Wuhan, China.
It is certainly possible that there are other cases that have not been reported. The Global Consortium Study of Neurological Dysfunctions in COVID-19 is actively underway to find out how often neurological problems like Guillain-Barre Syndrome is seen in hospitalized COVID-19 patients. Also, just because Guillain-Barre Syndrome occurs in a patient diagnosed with COVID-19, that does not imply that it was caused by the virus; this still may be a coincident occurrence. More research is needed to understand how the two events are related.
Due to the pandemic and infection-containment considerations, diagnostic tests, such as a nerve conduction study that used to be routine for patients with suspected Guillain-Barre Syndrome, are more difficult to do. In both U.S. cases, the initial diagnosis and treatment were all based on clinical examination by a neurological experts rather than any tests. Both patients survived but with significant residual weakness at the time these case reports came out, but that is not uncommon for Guillain-Barre Syndrome patients. The road to recovery may sometimes be long, but many patients can make a full recovery with time.
Though the reported cases of Guillain-Barre Syndrome so far all have severe symptoms, this is not uncommon in a pandemic situation where the less sick patients may stay home and not present for medical care for fear of being exposed to the virus. This, plus the limited COVID-19 testing capability across the U.S., may skew our current detection of Guillain-Barre Syndrome cases toward the sicker patients who have to go to a hospital. In general, the majority of Guillain-Barre Syndrome patients do recover, given enough time. We do not yet know whether this is true for COVID-19-related cases at this stage of the pandemic. We and colleagues around the world are working around the clock to find answers to these critical questions.
Sherry H-Y. Chou is an Associate Professor of Critical Care Medicine, Neurology, and Neurosurgery, University of Pittsburgh.
Aarti Sarwal is an Associate Professor, Neurology, Wake Forest University.
Neha S. Dangayach is an Assistant Professor of Neurology and Neurosurgery, Icahn School of Medicine at Mount Sinai.
Disclosure statement: Sherry H-Y. Chou receives funding from The University of Pittsburgh Clinical Translational Science Institute (CTSI), the National Institute of Health, and the University of Pittsburgh School of Medicine Dean's Faculty Advancement Award. Sherry H-Y. Chou is a member of Board of Directors for the Neurocritical Care Society. Neha S. Dangayach receives funding from the Bee Foundation, the Friedman Brain Institute, the Neurocritical Care Society, InCHIP-UConn Center for mHealth and Social Media Seed Grant. She is faculty for emcrit.org and for AiSinai. Aarti Sarwal does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.
Reposted with permission from The Conversation.
One of the initial reasons social distancing guidelines were put in place was to allow the healthcare system to adapt to a surge in patients since there was a critical shortage of beds, ventilators and personal protective equipment. In fact, masks that were designed for single-use were reused for an entire week in some hospitals.
- Silent Threat of the Coronavirus: America's Dependence on Chinese ... ›
- Rich Countries Are Buying up Medical Supplies, Leaving Poor ... ›